17-7675052-C-G
Variant names: 
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000546.6(TP53):c.559+1G>C variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
 Genomes: not found (cov: 33) 
Consequence
 TP53
NM_000546.6 splice_donor, intron
NM_000546.6 splice_donor, intron
Scores
 2
 4
 1
 Splicing: ADA:  0.9999  
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  4.21  
Publications
2 publications found 
Genes affected
 TP53  (HGNC:11998):  (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016] 
TP53 Gene-Disease associations (from GenCC):
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
 - Li-Fraumeni syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
 - Li-Fraumeni syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
 - adrenocortical carcinoma, hereditaryInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
 - sarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - bone marrow failure syndrome 5Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
 - colorectal cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
 - choroid plexus carcinomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Pathogenic. The variant received 12 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant,  LoF is a know mechanism of disease, No cryptic splice site detected.  Exon removal results in frameshift change. 
PM2
Very rare variant in population databases, with high coverage; 
PP5
Variant 17-7675052-C-G is Pathogenic according to our data. Variant chr17-7675052-C-G is described in ClinVar as Pathogenic. ClinVar VariationId is 4189257.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 33 
GnomAD3 genomes 
Cov.: 
33
GnomAD4 exome Cov.: 35 
GnomAD4 exome 
Cov.: 
35
GnomAD4 genome  Cov.: 33 
GnomAD4 genome 
Cov.: 
33
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Uncertain 
 DANN 
 Uncertain 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Uncertain 
D 
 PhyloP100 
 GERP RS 
Splicing
Name
Calibrated prediction
Score
Prediction
 dbscSNV1_ADA 
 Pathogenic 
 dbscSNV1_RF 
 Pathogenic 
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 DS_DG_spliceai 
Position offset: 47
 DS_DL_spliceai 
Position offset: 1
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.